Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Complementary and alternative medicine in alopecia areata.
Walk them or no leg to stand on! Diagnostic delay of neurologic conditions in young children.
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-Commentary.
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system.
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
Role of myelin auto-antigens in pain: a female connection.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Neurofilament light chain level is a weak risk factor for the development of MS.
Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population.
Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.
XPC deficiency is related to APE1 and OGG1 expression and function.
Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
Development and Validity of Western University's On-Road Assessment.
Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
Statins: a revised appraisal for potential additional future treatment indications.
Progressive multifocal leukoencephalopathy.
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities.
Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.
Isoaspartic acid is present at specific sites in myelin basic protein from multiple sclerosis patients: could this represent a trigger for disease onset?
Olfactory functioning in early multiple sclerosis: Sniffin' Sticks Test study.

Pages